- 1. HPV
- [A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation. ( NCI )] (UMLS (HL7) C1512511) HPV Vaccine;
Human Papilloma Virus Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 12. HPV-Related Cervical Squamous Cell Carcinoma
- (UMLS (NCI) C1334052) Human Papilloma Virus Related Cervical Squamous Cell Carcinoma;
Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma;
=Neoplastic Process |
- 2. HPV
- [(pap-ih-LO-ma-VYE-rus) A virus that causes abnormal tissue growth (warts) and is often associated with some types of cancer. ( NCI )] (UMLS (NCI) C0021344) =Virus =Papilloma Virus;
| - 13. HPV-Related Endocervical Adenocarcinoma
- (UMLS (NCI) C1334053) Human Papilloma Virus Related Endocervical Adenocarcinoma;
Human Papilloma Virus-Related Endocervical Adenocarcinoma;
=Neoplastic Process |
- 3. HPV 16 E6 Peptide
- [A synthetic peptide sequence of human papillomavirus (HPV) type 16 oncoprotein E6. The E6 oncoprotein is implicated in the tumorigenesis of cervical carcinoma. Vaccination with HPV 16 E6 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells expressing the E6 oncoprotein, resulting in tumor cell lysis. ( NCI )] (UMLS (NCI) C0133938) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 14. HPV-Related Esophageal Squamous Cell Carcinoma
- (UMLS (NCI) C1334054) Human Papilloma Virus Related Esophageal Squamous Cell Carcinoma;
Human Papilloma Virus-Related Esophageal Squamous Cell Carcinoma;
=Neoplastic Process |
- 4. HPV DNA Probes
- [DNA probes specific for the identification of human papilloma virus. ( MSH )] (UMLS (NCI) C0012895) =Nucleic Acid, Nucleoside, or Nucleotide; Indicator, Reagent, or Diagnostic Aid
| - 15. HPV-Related Malignancy
- (UMLS (NCI) C1334055) Human Papilloma Virus-Related Malignancy;
Human Papilloma Virus-Related Malignant Neoplasm;
=Neoplastic Process |
- 5. HPV-16
- [A strain of the human papillomavirus virus, (HPV16), has been directly linked to cervical cancer and is significantly associated with invasiveness. The papillomavirus virus constitutes a protein coat (capsid) surrounding a circular, double-stranded DNA organised into coding and non-coding regions, and induces skin and mucosal epithelial lesions. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 virus genome into the host chromosome. The event occurs with disruption or deletion of the E2 ORF followed by inactivation of the E2 regulatory protein. ( NCI )] (UMLS (NCI) C0999806) Human Papillomavirus-16;
=Virus | - 16. HPV-Related Penile Squamous Cell Carcinoma
- (UMLS (NCI) C1334056) Human Papilloma Virus Related Penile Squamous Cell Carcinoma;
Human Papilloma Virus-Related Penile Squamous Cell Carcinoma;
=Neoplastic Process |
- 6. HPV-18
- [A strain of the human papillomavirus virus, (HPV18), has been directly linked to cervical cancer and plays a role in the pathogenesis of the disease. The papillomavirus virus constitutes a protein coat (capsid) surrounding a circular, double-stranded DNA organised into coding and non-coding regions, and induces skin and mucosal epithelial lesions. The virus integrates its DNA at specific chromosomal locations, such as 8q24 and 12q15, which harbours both HPV18 and HPV16. The use of molecular markers such as HPV18 DNA type may allow the identification of patients with early stage cervical cancer at high risk for disease recurrence. ( NCI )] (UMLS (NCI) C0999807) Human Papillomavirus-18;
=Virus | - 17. HPV-Related Squamous Cell Carcinoma
- (UMLS (NCI) C1334057) Human Papilloma Virus Related Squamous Cell Carcinoma;
Human Papilloma Virus-Related Squamous Cell Carcinoma;
=Neoplastic Process |
- 7. HPV-6
- [Genital warts caused by HPV 6 and 11 are the most common STD in the United States. Over a million cases are seen per year. ( NCI )] (UMLS (NCI) C1005556) Human Papillomavirus Type 6;
Human Papillomavirus-6 =Virus | - 18. HPV-Related Verrucous Carcinoma
- (UMLS (NCI) C1334058) Human Papilloma Virus Related Verrucous Carcinoma;
Human Papilloma Virus-Related Verrucous Carcinoma;
=Neoplastic Process |
- 8. HPV-Related Adenocarcinoma
- (UMLS (NCI) C1334048) Human Papilloma Virus Related Adenocarcinoma;
Human Papilloma Virus-Related Adenocarcinoma;
=Neoplastic Process | - 19. HPV-Related Vulvar Squamous Cell Carcinoma
- (UMLS (NCI) C1334059) Human Papilloma Virus Related Vulvar Squamous Cell Carcinoma;
Human Papilloma Virus-Related Vulvar Squamous Cell Carcinoma;
=Neoplastic Process |
- 9. HPV-Related Anal Squamous Cell Carcinoma
- [An anal squamous cell carcinoma related to infection with sexually transmittable human papilloma virus. ( NCI )] (UMLS (NCI) C1334049) Human Papilloma Virus Related Anal Squamous Cell Carcinoma;
Human Papilloma Virus-Related Anal Squamous Cell Carcinoma;
=Neoplastic Process | - 20. HPV16 E7
- (UMLS (NCI) C0069508) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 10. HPV-Related Carcinoma
- (UMLS (NCI) C1334050) Human Papilloma Virus Related Carcinoma;
Human Papilloma Virus-Related Carcinoma;
=Neoplastic Process | - 21. HPV16 E7/PADRE 965.10
- [A synthetic agent derived from human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas. PADRE(R) is a proprietary family of molecules that enhances the immune systems response against an administered immunogen such as the HPV E7 nuclear protein. (NCI04) ( NCI )] (UMLS (NCI) C0338214) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 11. HPV-Related Cervical Carcinoma
- (UMLS (NCI) C1334051) Human Papilloma Virus Related Cervical Carcinoma;
Human Papilloma Virus-Related Cervical Carcinoma;
=Neoplastic Process | |
home
